DB05081ExperimentalSmall molecule
JB991 is a cyclopentenone prostaglandin analogue intended for treatment of psoriasis. The drug exerts marked antiproliferative and pro-apoptotic effect in human keratinocytes and fibroblasts in vitro. In addition a closely... In addition a closely related cyclopentenone prostaglandin analogue has been shown to exert marked anti-inflammatory effect in vivo in an animal model.
- Primary indication
- Investigated for use/treatment in psoriasis and psoriatic disorders and skin infections/disorders.Curator reviewed
- Code names
- JB991
Which companies are running trials of JB991, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account